QBiotics Group

QBiotics is a life sciences company developing novel small molecule anticancer and wound healing pharmaceuticals. Their lead oncology product, tigilanol tiglate, has potential to treat a broad range of solid tumors and is marketed as STELFONTA for treatment of canine mast cell tumors. They are based in Yungaburra, Australia.